AB Science announced today that it has signed an agreement with historical shareholders to implement a joint strategy to increase the value of masitinib

Ads

You May Also Like

MDxHealth: SelectMDx Study Demonstrates Cost-effectiveness in US Healthcare System

NEWS RELEASE  REGULATED INFORMATION                                                                                                                    Data published in Journal of Urology reports over ...